BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published online November 22, 2006
British Journal of Radiology (2007) 80, 274-278
© 2007 British Institute of Radiology
doi: 10.1259/bjr/28164599

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuczer, D
Right arrow Articles by Plotkin, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuczer, D
Right arrow Articles by Plotkin, M

123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study

D Kuczer, MD 2 A Feußner , MD 2 R Wurm, MD 2 P Wust, PhD 2 R Michel, PhD 2 F Stockhammer 3 T Denecke, MD 1 H Amthauer, MD 1 R Felix, MD, PhD 1 and M Plotkin, MD 1

1 Department of Radiology, Nuclear Medicine and Radiooncology, Campus Virchow-Klinikum, 2 Department of Radiation Therapy, Campus Mitte, 3 Department of Neurosurgery, Campus Virchow-Klinikum, University Clinic Charité, Berlin, Germany


Figure 1
View larger version (27K):
[in this window]
[in a new window]

 
Figure 1. A 47-year-old female patient (patient no.1) suffering from glioblastoma in the left frontal lobe presented 2 weeks after partial tumour resection. (a) The T1 weighted MR scan shows slight contrast media accumulations around the resection area. (b) Single photon emission computed tomography (SPECT) scan and (c) fused image demonstrate a high tracer uptake around the resection defect. (d) The control SPECT study following application of 40 Gy shows a reduction of the intratumoural 123I-methyltyrosine (IMT) uptake, as compared with the baseline study. The control investigation 7 months after completing the therapy (c) demonstrates no further changes of the tracer uptake in the lesion. In the follow up of 34 months, the patient was only slightly hindered by the tumour.

 

Figure 2
View larger version (9K):
[in this window]
[in a new window]

 
Figure 2. Amino acid transport under radiation therapy/at baseline in patients with high grade glioma in relation to survival. Changes in T/Bmean were not significantly correlated with survival: r (Spearman) = –0.1; p = 0.973.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2007 by the British Institute of Radiology.